IL6 and neoplasm: While acute DNA damage sensing initially stimulates anti-tumor immunity through Type I interferons, persistent signaling in senescent cells chronically drives a pro-tumorigenic SASP (e.g., IL-6, MMPs) that facilitates immune evasion and metastasis [48,49].